AIkido Pharma Inc. (AIKI) is a publicly traded company in the Unknown sector. Across all available filings, 8 corporate insiders have executed 42 transactions totaling $1.6M, demonstrating a bullish sentiment with $1.6M in net insider flow. The most recent transaction on Dec 19, 2022 involved a purchase of 5,000 shares valued at $17.9K.
No significant insider buying has been recorded for AIKI in the recent period.
No significant insider selling has been recorded for AIKI in the recent period.
Based on recent SEC filings, insider sentiment for AIKI is bullish with an Insider Alignment Score of 100/100 and a net flow of $1.6M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at AIkido Pharma Inc. (AIKI) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 8 insiders are actively trading AIKI stock, having executed 42 transactions in the past 90 days. The most active insider is Kyle Michael Wool (Executive), who has made 13 transactions totaling $1.0M.
Get notified when executives and directors at AIKI file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 19, 2022 | Michael Wool Kyle | Executive | Purchase | 5,000 | $3.59 | $17.9K | |
| Dec 16, 2022 | Yu Soo | Executive | Purchase | 5,000 | $3.71 | $18.6K | |
| Dec 15, 2022 | Michael Wool Kyle | Executive | Purchase | 5,000 | $3.69 | $18.4K | |
| Dec 14, 2022 | Hayes Anthony | Executive | Purchase | 4,500 | $3.69 | $16.6K | |
| Dec 14, 2022 | Yu Soo | Executive | Purchase | 4,500 | $3.69 | $16.6K | |
| Dec 13, 2022 | Michael Wool Kyle | Executive | Purchase | 5,000 | $3.70 | $18.5K | |
| Dec 13, 2022 | Hayes Anthony | Executive | Purchase | 5,000 | $3.70 | $18.5K | |
| Dec 12, 2022 | Hayes Anthony | Executive | Purchase | 5,000 | $3.63 | $18.1K | |
| Dec 12, 2022 | Michael Wool Kyle | Executive | Purchase | 5,000 | $3.63 | $18.1K | |
| Dec 9, 2022 | Michael Wool Kyle | Executive | Purchase | 5,000 | $3.68 | $18.4K | |
| Dec 9, 2022 | Hayes Anthony | Executive | Purchase | 5,000 | $3.68 | $18.4K | |
| Dec 8, 2022 | Hayes Anthony | Executive | Purchase | 5,000 | $3.56 | $17.8K | |
| Dec 8, 2022 | Michael Wool Kyle | Executive | Purchase | 5,000 | $3.56 | $17.8K | |
| Dec 7, 2022 | Hayes Anthony | Executive | Purchase | 5,000 | $3.48 | $17.4K | |
| Dec 7, 2022 | Michael Wool Kyle | Executive | Purchase | 5,000 | $3.48 | $17.4K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 28 | $1.6M | 54.0% |
Award(A) | 14 | $1.4M | 46.0% |
Insiders at AIkido Pharma Inc. are accumulating shares at an accelerated pace. With 8 insiders making 42 transactions totaling $1.6M in purchases versus $0 in sales, the net buying activity of $1.6M signals strong executive confidence. Kyle Michael Wool (Executive) leads the buying activity with $1.0M in transactions across all time.